Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAS-102 in Asian patients with metastatic colorectal cancer
NCT01955837Phase 3Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Sep 2013
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of trifluridine + tipiracil in metastatic colorectal cancer (mCRC), sponsored by Taiho Pharmaceutical Co., Ltd.. Started Sep 2013; status: completed.
02
Drugs
trifluridine + tipiracil
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT01955837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01955837.